Aerosol vs injected epinephrine in acute asthma

Area of Science:

• Pulmonology
• Emergency Medicine
• Pharmacology

Background:

• Acute asthma exacerbations require prompt and effective treatment.
• Epinephrine is a bronchodilator used in asthma management.
• The route of administration for epinephrine may influence its efficacy and side effect profile.

Purpose of the Study:

• To compare the efficacy and safety of subcutaneous (injected) versus aerosolized (inhaled) epinephrine in patients with acute asthma.
• To determine if the route of epinephrine administration is dependent on asthma severity.

Main Methods:

• Prospective, double-blind, randomized controlled trial.
• Twenty-five patients with acute asthma were assigned to receive either subcutaneous epinephrine with aerosol placebo or aerosol epinephrine with injected placebo.
• Asthma severity was categorized based on peak expiratory flow rate (PEFR).

Main Results:

• In patients with severe airway obstruction (PEFR < 120), subcutaneous epinephrine was significantly more effective than aerosol epinephrine after one hour (P < 0.005).
• In patients with mild to moderate asthma (PEFR > 120), both administration routes showed equal efficacy.
• Aerosolized epinephrine resulted in fewer side effects compared to injected epinephrine in patients with mild to moderate asthma (P < 0.001).

Conclusions:

• Subcutaneous epinephrine is superior to aerosol epinephrine for treating severe acute asthma.
• For mild to moderate acute asthma, inhaled epinephrine offers comparable efficacy to injected epinephrine with improved tolerability.
• Route of administration is a critical factor in epinephrine therapy for acute asthma, influenced by disease severity.